Location: Home
  • search
  • go
  • Relate News
  • 11/17/2020NMPA Publicizes the List of Reference Formulations for GQCE Studies (3...
  • 11/16/2020Merck and Transcenta Collaborate to Advance Continuous Biomanufacturin...
  • 11/16/2020Rhodiola to Develop and Market Russia's Sputnik-V Vaccine in China
  • 11/16/2020Tracon Pharma Files NDA for Anticancer Envafolimab in China
  • 11/13/2020Takeda and Zhongchao Expand Scope of Cooperation in China
  • 11/13/2020Recent Executive Moves
  • 11/13/2020What to Expect in China's 14th Five Year Plan? Decoding the Fifth Plen...
  • 11/12/2020Bloomberg: China Under Pressure to Reveal Covid-19 Vaccine Data After ...
  • 11/12/2020Aravive and 3D Medicines Announce Strategic Collaboration for AVB-500 ...
  • 11/12/2020Chinese Biotech Adagene Plans $200M U.S. IPO
  • 11/12/2020NMPA Solicits Comments on Draft Provisions for Supervision and Adminis...
  • 11/12/2020China's Flu Vaccine Supply Reaches Five-Year Peak
  • 11/12/2020Apollomics Granted IND Approval for APL-102 to Initiate a Phase 1 Stud...
  • 11/12/2020Takeda, OrigiMed to Develop Genomic-based Clinical Treatment Platform
  • 11/11/2020Takeda Reinstates Its Commitment to China with Plans to Launch 15 New ...
  • 11/11/2020Hainan Lecheng Expands Its Global Special Drug Insurance Online to All...
  • 11/11/2020SAMR Releases Draft Anti-Monopoly Rules To Scrutinize Online Platforms...
  • 11/11/2020NHSA Concludes Product Adjustment Evaluation of 2020 NDRL
  • 11/11/2020NMPA Accepts Fosun Pharma Clinical Trial Application Of mRNA Vaccine C...
  • 11/11/2020Pfizer Inks Deal with Dynamiker
  • 11/11/2020CStone Announces NMPA Acceptance of Its NDA for Sugemalimab in Firs...
  • 11/11/2020Nicox Begins 2nd P3 Trial of NCX 470 for Open-angle Glaucoma or Ocular...
  • 11/11/2020FiercePharma: Ten Biotechs to Know in China
  • 11/11/2020Facing The Chinese Challenge – Are Indian Pharmaceutical Companies Up...
  • 11/10/2020Ambrx Closes US$200M Crossover Financing Round
  • 11/10/2020CDE Issues the Pharmaceutical Dossiers Requirements for Communication ...
  • 11/10/2020HitGen Licenses Its Trk/ROS1 Inhibitor HG030 to Baiyunshan in China
  • 11/10/2020Innovent Reports on Phase 1a Results of CD47 mAb (Letaplimab) for Ad...
  • 11/9/2020AstraZeneca Unveils New R&D center in Jing'an, Shanghai
  • 11/9/2020British Genomics Start-up Congenica Sells Stake to China's Tencent
  • Page:214/777 Total number of articles:23289: [First][<<] [212] [213] [214] [215] [216] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group